Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 6/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30625928 | 0.85 | KIF11 (0.56) | KIF11KCNN4L3MBTL1 | |
| SCHEMBL29634957 | 0.82 | KIF11 (0.49) | KIF11LMNAPOLB | |
| SCHEMBL29562983 | 0.81 | KIF11 (0.47) | KIF11LMNAPOLBALDH1A1KCNN4 | |
| SCHEMBL3607590 | 0.81 | TBXA2R (0.51) | KIF11HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL6751139 | 0.80 | KIF11 (0.58) | KIF11HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL2238290 | 0.80 | KIF11 (0.60) | KIF11 | |
| SCHEMBL1268931 | 0.80 | KIF11 (0.60) | KIF11 | |
| SCHEMBL30148489 | 0.80 | KIF11 (0.60) | KIF11 | |
| SCHEMBL7168986 | 0.79 | KIF11 (0.52) | KIF11HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL29649596 | 0.79 | ALDH1A1 (0.51) | HDAC3HDAC1HDAC2HDAC8NCOR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116669773-A | Method for functionalizing nanoparticles | 易达制药公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-116568335-A | Folate receptor targeted nanoparticle drug conjugate and application thereof | 易达制药公司 | 2023-08-08 | — | — | CN | disclosed |
| EP-4106820-A1 | METHODS OF FUNCTIONALIZING NANOPARTICLES | Elucida Oncology, Inc. (US) | 2022-12-28 | — | — | EP | disclosed |
| WO-2022093794-A9 | METHODS OF FUNCTIONALIZING NANOPARTICLES | ELUCIDA ONCOLOGY, INC. (US) | 2022-06-09 | — | — | WO | disclosed |
| WO-2022093794-A1 | METHODS OF FUNCTIONALIZING NANOPARTICLES | ELUCIDA ONCOLOGY, INC. (US) | 2022-05-05 | — | — | WO | disclosed |